PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
Parkinsonís Research Now: Tests, Treatments and More
Welcome to Parkinson’s Research Now, which provides information on the latest science advances and what they mean for you. In this issue, we discuss two of the most significant challenges remaining in Parkinson’s: the development of biomarkers, or tests, that can properly diagnose and track Parkinson’s, and the discovery of new treatments to ease its symptoms.
Tests: DaTscan and Diagnosis
In 2011, the United States Food and Drug Administration (FDA) approved the use of DaTscan for people with suspected Parkinson’s syndromes. A new study, published in the March 6 issue of Neurology by Raúl de la Fuente-Fernández, M.D., at the Hospital A. Marcide in Spain, concludes that DaTscan is no more accurate in diagnosing Parkinson’s than a doctor who specializes in movement disorders. What does it mean?
Treatments: Bicycling Studies for Freezing of Gait
Do you or a loved one experience freezing of gait? A new study published in the September 20 online edition of the Journal of Neurology, Neurosurgery, and Psychiatry and led by Bastiaan R. Bloem, M.D., Ph.D., of Radboud University Nijmegen Medical Center, indicates some people with this symptom may retain the ability to ride a bicycle. Does this point us toward a realistic exercise option for people who find it difficult to perform other activities?
Treatments: Neupro® Re-Approved
FDA has approved the reformulation of the rotigotine transdermal system (Neupro®) for the treatment of early and advanced stage Parkinson's disease. The manufacturer states that Neupro will be available in US pharmacies in July 2012.
PDF Gala Establishes New Fellowship
Tonight, PDF will hold its annual gala Bal du Printemps in New York, NY. We will honor Isobel Robins Konecky for her years of commitment to Parkinson’s research. A major portion of proceeds benefit the Ronald and Isobel Konecky Research Fellowship in Movement Disorders, this year funding the work of Christopher W. Hess, M.D., of Columbia University Medical Center.
Support the gala anytime today by texting PDFGALA to 82257 and your name and message will be displayed at the event. Be sure to include your pledge, name and short message.
If you have questions about these reports, please feel free to call PDF’s HelpLine at (800) 457-6676 or email us at email@example.com.
Not getting these eblasts? Sign up to receive them in your inbox.
PDF's work in Parkinson's research, education and advocacy is made possible by your contributions. Make a donation today to support our mission. Thank you for your generosity.
If you have or believe you have Parkinson’s disease, then promptly consult a physician and follow your physician’s advice. This email is not a substitute for a physician’s diagnosis of Parkinson’s disease or for a physician’s prescription of drugs, treatment or operations for Parkinson’s.